Class information for:
Level 1: VIGABATRIN//GAMMA VINYL GABA//VISUAL FIELD CONSTRICTION

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
15080 732 30.0 63%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
143 3       EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR 64226
230 2             ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY 20331
15080 1                   VIGABATRIN//GAMMA VINYL GABA//VISUAL FIELD CONSTRICTION 732

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 VIGABATRIN authKW 4459688 34% 43% 246
2 GAMMA VINYL GABA authKW 330945 3% 36% 22
3 VISUAL FIELD CONSTRICTION authKW 320869 1% 77% 10
4 REFRACTORY COMPLEX PARTIAL SEIZURES authKW 291995 1% 100% 7
5 INTRAMYELINIC EDEMA authKW 148306 1% 44% 8
6 AUDITORY DISTURBANCE authKW 111234 1% 67% 4
7 MARYLAND EYE CARE address 93854 0% 75% 3
8 VISUAL FIELD DEFECT authKW 93085 3% 9% 24
9 VISUAL FIELD LOSS authKW 85791 2% 17% 12
10 REGULATORY DEV REGISTRAT address 83427 0% 100% 2

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Clinical Neurology 10525 52% 0% 380
2 Ophthalmology 1039 11% 0% 78
3 Neurosciences 875 22% 0% 160
4 Pharmacology & Pharmacy 688 20% 0% 145
5 Pediatrics 213 7% 0% 50
6 Psychiatry 197 7% 0% 51
7 Behavioral Sciences 84 3% 0% 21
8 Toxicology 35 3% 0% 21
9 Medicine, General & Internal 20 4% 0% 31
10 Engineering, Biomedical 10 2% 0% 11

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 MARYLAND EYE CARE 93854 0% 75% 3
2 REGULATORY DEV REGISTRAT 83427 0% 100% 2
3 CARDIFF OPTOMETRY VIS SCI 68250 1% 27% 6
4 NEUROPHARMACOL PRECLIN TOXICOL 55617 0% 67% 2
5 BE WELL 41714 0% 100% 1
6 C MONDINO FDNCHILD NEUROPSYCHIAT 41714 0% 100% 1
7 CARE OF ST ANDREA HOSP 41714 0% 100% 1
8 CELL NEUROBIOL DOHERTY EYE 41714 0% 100% 1
9 DIPARTIMENTO SALUTE PUBBLICA BIOSTATISTICA 41714 0% 100% 1
10 DRUG SAFETY EACH UNIT 41714 0% 100% 1

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 EPILEPSIA 33848 12% 1% 85
2 EPILEPSY RESEARCH 15530 5% 1% 38
3 SEIZURE 10934 1% 7% 4
4 AKTUELLE NEUROLOGIE 7540 2% 1% 18
5 SEIZURE-EUROPEAN JOURNAL OF EPILEPSY 5542 2% 1% 18
6 ACTA NEUROLOGICA SCANDINAVICA 4986 4% 0% 27
7 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 4291 4% 0% 29
8 DOCUMENTA OPHTHALMOLOGICA 4173 2% 1% 15
9 JOURNAL OF CHILD NEUROLOGY 2762 2% 0% 18
10 NEUROLOGY 2234 5% 0% 34

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 VIGABATRIN 4459688 34% 43% 246 Search VIGABATRIN Search VIGABATRIN
2 GAMMA VINYL GABA 330945 3% 36% 22 Search GAMMA+VINYL+GABA Search GAMMA+VINYL+GABA
3 VISUAL FIELD CONSTRICTION 320869 1% 77% 10 Search VISUAL+FIELD+CONSTRICTION Search VISUAL+FIELD+CONSTRICTION
4 REFRACTORY COMPLEX PARTIAL SEIZURES 291995 1% 100% 7 Search REFRACTORY+COMPLEX+PARTIAL+SEIZURES Search REFRACTORY+COMPLEX+PARTIAL+SEIZURES
5 INTRAMYELINIC EDEMA 148306 1% 44% 8 Search INTRAMYELINIC+EDEMA Search INTRAMYELINIC+EDEMA
6 AUDITORY DISTURBANCE 111234 1% 67% 4 Search AUDITORY+DISTURBANCE Search AUDITORY+DISTURBANCE
7 VISUAL FIELD DEFECT 93085 3% 9% 24 Search VISUAL+FIELD+DEFECT Search VISUAL+FIELD+DEFECT
8 VISUAL FIELD LOSS 85791 2% 17% 12 Search VISUAL+FIELD+LOSS Search VISUAL+FIELD+LOSS
9 VIGABATRIN TOXICITY 83427 0% 100% 2 Search VIGABATRIN+TOXICITY Search VIGABATRIN+TOXICITY
10 AMINOBUTYRATE AMINOTRANSFERASE 74153 1% 44% 4 Search AMINOBUTYRATE+AMINOTRANSFERASE Search AMINOBUTYRATE+AMINOTRANSFERASE

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref.
in cl.
Shr. of ref. in
cl.
Citations
1 WATERHOUSE, EJ , MIMS, KN , GOWDA, SN , (2009) TREATMENT OF REFRACTORY COMPLEX PARTIAL SEIZURES: ROLE OF VIGABATRIN.NEUROPSYCHIATRIC DISEASE AND TREATMENT. VOL. 5. ISSUE . P. 505-515 66 85% 17
2 PLANT, GT , SERGOTT, RC , (2011) UNDERSTANDING AND INTERPRETING VISION SAFETY ISSUES WITH VIGABATRIN THERAPY.ACTA NEUROLOGICA SCANDINAVICA. VOL. 124. ISSUE . P. 57 -71 63 78% 16
3 MAGUIRE, MJ , HEMMING, K , WILD, JM , HUTTON, JL , MARSON, AG , (2010) PREVALENCE OF VISUAL FIELD LOSS FOLLOWING EXPOSURE TO VIGABATRIN THERAPY: A SYSTEMATIC REVIEW.EPILEPSIA. VOL. 51. ISSUE 12. P. 2423 -2431 43 96% 42
4 SERGOTT, RC , WHELESS, JW , SMITH, MC , WESTALL, CA , KARDON, RH , ARNOLD, A , FOROOZAN, R , SAGAR, SM , (2010) EVIDENCE-BASED REVIEW OF RECOMMENDATIONS FOR VISUAL FUNCTION TESTING IN PATIENTS TREATED WITH VIGABATRIN.NEURO-OPHTHALMOLOGY. VOL. 34. ISSUE 1. P. 20 -35 44 85% 14
5 KJELLSTROM, U , ANDREASSON, S , PONJAVIC, V , (2011) ELECTROPHYSIOLOGICAL EVALUATION OF RETINAL FUNCTION IN CHILDREN RECEIVING VIGABATRIN MEDICATION.JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS. VOL. 48. ISSUE 6. P. 357-365 49 77% 0
6 GRANT, SM , HEEL, RC , (1991) VIGABATRIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN EPILEPSY AND DISORDERS OF MOTOR CONTROL.DRUGS. VOL. 41. ISSUE 6. P. 889-926 74 67% 254
7 GIDAL, BE , PRIVITERA, MD , SHETH, RD , GILMAN, JT , (1999) VIGABATRIN: A NOVEL THERAPY FOR SEIZURE DISORDERS.ANNALS OF PHARMACOTHERAPY. VOL. 33. ISSUE 12. P. 1277 -1286 62 78% 23
8 PELLOCK, JM , (2011) BALANCING CLINICAL BENEFITS OF VIGABATRIN WITH ITS ASSOCIATED RISK OF VISION LOSS.ACTA NEUROLOGICA SCANDINAVICA. VOL. 124. ISSUE . P. 83 -91 47 72% 7
9 WHELESS, JW , RAMSAY, RE , COLLINS, SD , (2007) VIGABATRIN.NEUROTHERAPEUTICS. VOL. 4. ISSUE 1. P. 163-172 55 65% 30
10 KJELLSTROM, U , ANDREASSON, S , PONJAVIC, V , (2014) ATTENUATION OF THE RETINAL NERVE FIBRE LAYER AND REDUCED RETINAL FUNCTION ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY AND FULL-FIELD ELECTRORETINOGRAPHY IN PATIENTS EXPOSED TO VIGABATRIN MEDICATION.ACTA OPHTHALMOLOGICA. VOL. 92. ISSUE 2. P. 149-157 38 79% 6

Classes with closest relation at Level 1



Rank Class id link
1 3055 LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE
2 23540 4 AMINOBUTYRATE AMINOTRANSFERASE//GAMMA AMINOBUTYRIC ACID AMINOTRANSFERASE//GABA AT
3 10778 WEST SYNDROME//INFANTILE SPASMS//HYPSARRHYTHMIA
4 19488 FENGABINE//GABAA RECEPTOR CHLORIDE IONOPHORE COMPLEX//PLASMA GABA
5 22777 BACLOFEN//CGP44532//OPERANT ORAL ALCOHOL SELF ADMINISTRATION
6 26122 N BENZYLOXYCARBONYLGLYCINE//1 3 DIACYLAMINOPROPAN 2 OLS//1 3 DIACYLAMINO 2 O ACYL PROPANES
7 14888 TIAGABINE//GABA TRANSPORTER//GABA UPTAKE INHIBITORS
8 32621 EEG THRESHOLD//BARBEXACLONE//BRAIN TO BLOOD RATIOS
9 20462 VERDUN HOSP//CHARCOAL HEMOPERFUSION//HEMOPERFUSION
10 31726 ETHAMBUTOL//TOXIC OPTIC NEUROPATHY//ETHAMBUTOL OPTIC NEUROPATHY

Go to start page